Brief: Leap Therapeutics Reports Updated Clinical Data From Sirexatamab Colorectal Cancer Study
23/06/2025 12:02
June 23 (Reuters) - Leap Therapeutics Inc LPTX.O: LEAP THERAPEUTICS REPORTS UPDATED CLINICAL DATA FROM SIREXATAMAB COLORECTAL CANCER STUDY AND ANNOUNCES EXPLORATION OF STRATEGIC ALTERNATIVES LEAP THERAPEUTICS INC - TO REDUCE WORKFORCE BY 75% LEAP THERAPEUTICS INC - TO EXPLORE SALE OR PARTNERSHIP FOR SIREXATAMAB AND FL-501 LEAP THERAPEUTICS INC - ESTIMATES $3.2 MILLION COST FOR WORKFORCE REDUCTION Source text: ID:nPn1vbpFCa Further company coverage: LPTX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cypherpunk Technologies
See all newsCypherpunk Technologies Inc reports results for the quarter ended June 30 - Earnings Summary
Cypherpunk Technologies swings to Q2 profit on Zcash gains
Cypherpunk Technologies Inc expected to post a loss of 3 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Chipotle Mexican Grill, J.B. Hunt, ABM Industries
U.S. STOCKS ON THE MOVE-G-III Apparel, Amneal Pharmaceuticals, BioCardia